Last reviewed · How we verify

NCT06815341

Risk Factors for Sub Mucosal Fibrosis During Achalasia Cardia: A Prospective Study

Status unknown Last updated 11 February 2025
What this trial tests

trial in Esophagus Disorder in 339 participants. Status unknown.

Timeline
14 August 2021
Primary endpoint
20 February 2025
20 April 2025

Quick facts

Lead sponsorAsian Institute of Gastroenterology, India
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment339
Start date14 August 2021
Primary completion20 February 2025
Estimated completion20 April 2025
Sites2 locations across India

Conditions studied

Sponsor

Asian Institute of Gastroenterology, India

Who can join

Adults 18 to 75, any sex, with Esophagus Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Classification for Stasis Esophagitis: Grade I Grade II Grade III Vascular pattern Obscured Obscured Obscured Mucosal thickening No Yes Yes Ulceration No Yes Yes Nodularity No No Yes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Asian Institute of Gastroenterology, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06815341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing